Wave Life Sciences Ltd.

05/24/2024 | News release | Distributed by Public on 05/24/2024 15:47

First clinical evidence for myocyte stem (satellite) cell targeting in DMD: Results from Part A of a Phase 1b/2 study of WVE-N531